The use of palivizumab monoclonal antibodyto control an outbreak of respiratory syncytial virus infection in a special care baby unit
- 1 July 2001
- journal article
- Published by Elsevier in Journal of Hospital Infection
- Vol. 48 (3) , 186-192
- https://doi.org/10.1053/jhin.2001.1002
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Respiratory syncytial virus infection in high risk infants and the potential impact of prophylaxis in a United Kingdom cohortArchives of Disease in Childhood, 2000
- Hospitalisation for RSV infection in ex-preterm infants---implications for use of RSV immune globulinArchives of Disease in Childhood, 2000
- Control of an outbreak of respiratory syncytial virus infection in immunocompromized adultsJournal of Hospital Infection, 2000
- RSV preventionArchives of Disease in Childhood, 2000
- Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk InfantsPediatrics, 1998
- Screening for respiratory syncytial virus and assignment to a cohort at admission to reduce nosocomial transmissionThe Journal of Pediatrics, 1990
- Respiratory syncytial virus infection in special care nurseryThe Lancet, 1990
- Respiratory syncytial virus infections in infants: Quantitation and duration of sheddingThe Journal of Pediatrics, 1976
- Quantitative Shedding Patterns of Respiratory Syncytial Virus in InfantsThe Journal of Infectious Diseases, 1975
- Respiratory Syncytial Virus Infection of the NewbornBMJ, 1970